Navigation Links
Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
Date:8/19/2008

MUMBAI, India and BALTIMORE, Aug. 19 /PRNewswire/ -- Lupin Ltd. announced today that the Company has entered into a multi-year promotion and marketing agreement for the AeroChamber Plus(R) line of products with Forest Laboratories, Inc. Under the terms of the agreement, Lupin Pharmaceuticals, Inc., USA, will use its 50 person sales force to promote the product to pediatricians.

AeroChamber Plus(R) is a Valved Holding Chamber (VHC) device that is used with metered dose inhalers to improve the delivery of medication to the lungs in the treatment of asthma and COPD. AeroChamber Plus(R) also reduces the deposition of medication in the mouth and throat and makes metered dose inhalers easier for patients to use by reducing the need to coordinate actuation of the inhaler with inhalation. AeroChamber Plus(R) is the most widely prescribed holding chamber in the United States and has been used by millions of patients since its introduction. Approximately two thirds of AeroChamber Plus(R) Valved Holding Chamber prescriptions (IMS 2007 data) are written by pediatricians.

"We are happy to strike this alliance with Forest. While the AeroChamber Plus(R) brand has a strong position in the Valved Holding Chamber market, we believe that this marketing alliance presents a significant opportunity for further growth of the franchise for Forest, resulting in value for both companies," said Vinita Gupta, President, LPI.

This agreement with Forest Laboratories, Inc. reflects Lupin's commitment to bring value additions to the US market to improve the overall health of the patient population. This alliance will also extend Lupin's presence in the respiratory segment and help strengthen its franchise with pediatricians.

About Lupin

Lupin Pharmaceuticals, Inc., headquartered in Baltimore, Maryland, is the wholly owned U.S. subsidiary of Mumbai based Lupin Limited, a leading Indian Pharmaceutical company. Lupin Limited develops, manufactures and markets a wide range of quality, affordable generic and branded generic formulations and APIs for the developed and the developing markets of the world. Twelve of Lupin's facilities have been inspected and approved by the U.S. Food & Drug Administration.

For the year ended March 2008, the Lupin's consolidated Revenues and Profit after Tax were Rs. 27730 million (USD 660.23 million) and Rs. 4083 million (USD 102 million) respectively.

The Company has secured global leadership position in Anti-TB and Cephalosporins and has a significant presence in the areas of Cardiovasculars (prils and statins), Diabetology, Asthma and NSAIDs. Currently positioned amongst the top five pharmaceutical companies of India, the Company is committed to achieve sustainable earnings and growth for all its stakeholders.

AeroChamber Plus(R) is a registered trademark of Trudell-Monaghan.

For More Information:

Lupin Pharmaceuticals, Inc.

Contact: Atul Gokhale

General Manager - Marketing

410-576-2000

Web site: http://www.lupinpharmaceuticals.com.


'/>"/>
SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets
2. Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for Suprax(R) 400 mg Tablets in the U.S.
3. Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets
4. Lupin Launches Ramipril Capsules
5. Lupin Receives USFDA Approval for Topiramate Tablets
6. Older Patients Less Likely to Be Taken to Trauma Centers
7. VA Opening Rural Health Resource Centers
8. AUDIO from Medialink and Pfizer: Community Health Centers Celebrated for Making Quality Care Available to Uninsured Americans
9. Nighttime Care Centers Introduce Mini C-Arm Mobile X-Ray Technology to Anne Arundel County
10. IPC The Hospitalist Company Enters Ohio and Pennsylvania Markets
11. Bederra Corp.s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... CA (PRWEB) , ... May ... ... approach to healthcare that considers individuals’ genetic characteristics and the physical and ... precision therapy work in sync. In personalized medicine, diagnosing an individual’s disease ...
(Date:5/31/2016)... ... 2016 , ... More than 80 representatives of the Hepatitis B Foundation ... Foundation held an event on National Hepatitis Testing Day outside of Philadelphia City Hall ... leading cause of liver cancer. , Foundation leaders and the citywide coalition they created, ...
(Date:5/31/2016)... San Jose, CA (PRWEB) , ... May 31, 2016 , ... ... collaboration , announces its strategic partnership with e-Jan Networks Co., the leading provider ... Japan enterprises are customers of e-Jan Networks’s leading CACHATTO remote access solution. ...
(Date:5/31/2016)... ... ... years ago it was revolutionary: enabling the people who hear distressing voices to speak ... approach has proven transformative, both for people who hear voices and for the field ... around the world, but it still lags in the United States. , Now, Gail ...
(Date:5/31/2016)... Fort Walton Beach, Florida (PRWEB) , ... May ... ... weather-forecasting technology to Jay Butch of CertainTeed Corporation, he knew it was something ... technology is as state-of-the-art and cutting-edge as it gets,” says Butch, CertainTeed’s Director ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... Mich. , May 31, 2016  Diplomat Pharmacy, Inc. ... pharmacy, has announced that Phil Hagerman , Chairman & ... the upcoming William Blair 36 th Annual Growth Stock ... Mr. Hagerman and Mr. Whelan are scheduled to present at ... Central Time. A live audio-only webcast of the presentation and ...
(Date:5/31/2016)... , May 31, 2016 ... ingredient in food, cosmetics and pharmaceuticals, with global volume ... worth US$ 1.6 Bn. Demand for aloe ... juices, and yogurts will continue its upward momentum in ... will also boost positive sentiment on aloe vera, with ...
(Date:5/31/2016)... , Isansys  Lifecare, a new generation digital healthcare ... wireless patient monitoring platform, as it ships more systems to hospitals ... Scotland and Norway ... launched earlier this year, is now being used in ground-breaking ... new technology significantly enhances the user experience and provides ...
Breaking Medicine Technology: